National Tuberculosis Advisory Committee multi-drug resistant tuberculosis: information paper (October 2007).
ثبت نشده
چکیده
Multi-drug resistant tuberculosis (MDRTB) is defined as a strain of Mycobacterium tuberculosis with resistance to at least isoniazid (H) and rifampicin (R), the two key drugs in TB treatment. Very recently, extensively drug-resistant tuberculosis (XDRTB) has gained notoriety and is defined as MDRTB with additional resistance to any fluoroquinolone, and to at least one of three injectable second-line anti-TB drugs (capreomycin, kanamycin, and amikacin) used in MDRTB treatment.
منابع مشابه
The BCG vaccine: information and recommendations for use in Australia. National Tuberculosis Advisory Committee update October 2012.
The Bacille Calmette-Guérin (BCG) vaccine since its first use in 1921 has been the subject of much controversy as to its effectiveness and applicability. BCG vaccination is still considered an important strategy in the National Tuberculosis Programs of countries with a high burden of tuberculosis (TB) because of its benefit to infants but its effect on the control of TB has been limited. By con...
متن کاملPattern of Adverse Effects of Drugs Used to Treat Multi Drug Resistant Tuberculosis
During treatment of multi drug resistant tuberculosis (MDR-TB), patients suffer from many adverse effects. Severe adverse effects may lead to refusal and discontinuation of treatment. Though national tuberculosis control programs are generally well structured, they do not collect information on adverse effects of drug directly. This study had been designed to observe the pattern of adverse effe...
متن کاملStudy of drug resistant cases among new pulmonary tuberculosis patients attending a tuberculosis center, Yangon, Myanmar.
A cross-sectional descriptive study was carried out at a tuberculosis center, Yangon, Myanmar from October 2003 to July 2004 to analyze the drug susceptibility of new sputum smear positive pulmonary tuberculosis patients. A total of 202 Mycobacterium tuberculosis isolates were tested for resistance to isoniazid, streptomycin, rifampicin and ethambutol. Resistance to at least one anti-tuberculos...
متن کاملFrom Alma-Ata to Almaty: a new start for primary health care.
www.thelancet.com Vol 372 October 18, 2008 1365 7 Keshavjee S, Gelmanova IY, Farmer PE, et al. Treatment of extensively drug-resistant tuberculosis in Tomsk, Russia: a retrospective cohort study. Lancet 2008; published online Aug 25. DOI:10.1016/S0140-6736(08) 61204-0. 8 Gandhi NR, Moll A, Sturm AW, et al. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with ...
متن کاملTh1/Th2 Imbalance and Elevated PD-L1 in Pleural Effusion Predict the Risk of Multi-Drug Resistant Tuberculous Pleuritis
Background: Patient immune status might be indicative of the variance in bacterial genetics in drug-resistant tuberculous pleuritis and could be used for predicting the risk of multi-drug resistant tuberculous pleuritis (MDR-TB). Objective: To determine the significance of Th2/Th1 ratio and concentration of PD-L1 in the pleural effusions for prediction of MDR-T...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- Communicable diseases intelligence quarterly report
دوره 31 4 شماره
صفحات -
تاریخ انتشار 2007